How does pending litigation affect the USPTO’s determination in a supplemental examination proceeding?

According to MPEP 2816, pending litigation does not directly affect the USPTO’s determination in a supplemental examination proceeding. The MPEP states: “In view of the statutory mandate to make the determination on the request within three months, the determination on the request based on the record before the examiner will be made without awaiting a…

Read More

What is “patentably indistinct subject matter” in the context of patent interferences?

“Patentably indistinct subject matter” refers to inventions or claims that are not substantially different from each other in terms of patentability. In the context of patent interferences, this concept is crucial. The MPEP 2308.03(c) states: “No second interference should occur between the same parties on patentably indistinct subject matter.” This means that if two parties…

Read More

What are the formal requirements for a patent term extension application?

The formal requirements for a patent term extension application are outlined in 37 CFR 1.740. Some key requirements include: Complete identification of the approved product Identification of the federal statute under which regulatory review occurred Date of product approval for commercial marketing or use For drug products, identification of each active ingredient Statement that the…

Read More

How are amendments made in patent reexamination proceedings?

Amendments in patent reexamination proceedings are made according to specific rules outlined in 37 CFR 1.530. The key points are: Amendments are made by filing a paper specifying changes to the patent specification, claims, or drawings. For specification changes, the entire text of added or rewritten paragraphs must be submitted with markings. For claim changes,…

Read More

What happens if a patent owner fails to respond to an Office action in an inter partes reexamination?

The consequences of a patent owner’s failure to respond to an Office action in an inter partes reexamination depend on the stage of the proceedings and whether any claims were found patentable: If no claims were found patentable, the prosecution will be terminated, and a certificate concluding the reexamination will be issued. If claims were…

Read More

Can a patent owner amend claims before the first Office action in inter partes reexamination?

No, a patent owner cannot amend claims before the first Office action in inter partes reexamination. MPEP 2660 clearly states: “Ordinarily, there will be no patent owner amendment to address in the first Office action of the inter partes reexamination, because 37 CFR 1.939(b) prohibits a patent owner amendment prior to first Office action.” This…

Read More

How are patent claim numbers handled during reexamination?

During patent reexamination, the numbering of existing patent claims must be preserved, and any new claims must follow a specific numbering convention. 37 CFR 1.530(g) states: “Patent claims may not be renumbered. The numbering of any claims added in the reexamination proceeding must follow the number of the highest numbered patent claim.” This rule ensures…

Read More

What information about patent claims is provided in the Official Gazette notice for reexamination certificates?

The Official Gazette notice for reexamination certificates provides important information about patent claims. As stated in MPEP 2291: “The Official Gazette notice will include… an indication of the status of each claim after the conclusion of the reexamination proceeding. Additionally, a representative claim will be published…” This means that readers can find: The status of…

Read More